Abstract
The health of the nuclear medicine and radiopharmaceutical industry relies on the ability to continue producing answers to the most pressing medical problems and to produce a continuous supply of the needed materials. Thus there is the need not only for research at the leading edge of medicine but for steady production for a number of years after the initial introduction of a product, especially, so the use of the material may be disseminated from the academic centers to the community hospitals.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Croft, B.Y. (1991). Regulatory Control of Radiopharmaceuticals. In: Emran, A.M. (eds) New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0626-7_45
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0626-7_45
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0628-1
Online ISBN: 978-1-4899-0626-7
eBook Packages: Springer Book Archive